138 related articles for article (PubMed ID: 23908504)
21. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effects of intravenous immunoglobulin as an add-on therapy to azathioprine for NMO-IgG-seropositive neuromyelitis optica spectrum disorders.
Lim YM; Kim H; Lee EJ; Kim HW; Kim HJ; Kim KK
Mult Scler Relat Disord; 2020 Jul; 42():102109. PubMed ID: 32387973
[TBL] [Abstract][Full Text] [Related]
23. Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies.
Souza PV; Pinto WB; Oliveira AS
Arq Neuropsiquiatr; 2014 Dec; 72(12):966-71. PubMed ID: 25465778
[TBL] [Abstract][Full Text] [Related]
24. Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality.
Aires DJ; Fraga G; Korentager R; Richie CP; Aggarwal S; Wick J; Liu DY
J Drugs Dermatol; 2013 Jun; 12(6):679-84. PubMed ID: 23839186
[TBL] [Abstract][Full Text] [Related]
25. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series.
Steger B; Madhusudan S; Kaye SB; Stylianides A; Romano V; Maqsood SE; Harper J; Ahmad S
Cornea; 2016 Dec; 35(12):1611-1614. PubMed ID: 27661067
[TBL] [Abstract][Full Text] [Related]
26. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.
Nieto-Aristizábal I; Martínez T; Urbano MA; Posso-Osorio I; Plata IF; Garcia-Robledo JE; Aragón CC; Santos VA; Tobón GJ
Lupus; 2019 Nov; 28(13):1566-1570. PubMed ID: 31653191
[TBL] [Abstract][Full Text] [Related]
27. Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review.
Kim EJ; Yoon SY; Park HS; Yoon HS; Cho S
Dermatol Ther; 2015; 28(5):287-90. PubMed ID: 25845419
[TBL] [Abstract][Full Text] [Related]
28. Infusing IVIG through Community Care Access Services in Patients with CIDP.
Katzberg HD; Rasutis V; Bril V
Can J Neurol Sci; 2016 Mar; 43(2):326-8. PubMed ID: 26552493
[No Abstract] [Full Text] [Related]
29. Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy.
Egawa M; Kanegane H; Imai K; Morio T; Miyasaka N
J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3092-3096. PubMed ID: 29614902
[TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulin therapy for neuromuscular disorders.
Ross MA
Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial.
Fukui S; Seki M; Minami T; Kotani K; Oka K; Yokomizo A; Matsubara D; Sato T; Nozaki Y; Saito M; Kikuchi Y; Miyamoto K; Monden Y; Yamagata T
Pediatr Rheumatol Online J; 2021 Jul; 19(1):107. PubMed ID: 34217297
[TBL] [Abstract][Full Text] [Related]
32. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.
Foster CS; Chang PY; Ahmed AR
Ophthalmology; 2010 May; 117(5):861-9. PubMed ID: 20045562
[TBL] [Abstract][Full Text] [Related]
33. Not all intravenous immunoglobulin preparations are equally well tolerated.
Feldmeyer L; Benden C; Haile SR; Boehler A; Speich R; French LE; Hofbauer GF
Acta Derm Venereol; 2010 Sep; 90(5):494-7. PubMed ID: 20814625
[TBL] [Abstract][Full Text] [Related]
34. Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Afzal S
J Neurol; 2019 Feb; 266(2):461-467. PubMed ID: 30556098
[TBL] [Abstract][Full Text] [Related]
35. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Nobile-Orazio E; Cocito D; Jann S; Uncini A; Beghi E; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Macchia R; Cavaletti G; Giannini F; Sabatelli M;
Lancet Neurol; 2012 Jun; 11(6):493-502. PubMed ID: 22578914
[TBL] [Abstract][Full Text] [Related]
36. Home IVIG for CIDP: a focus on patient centred care.
Katzberg HD; Rasutis V; Bril V
Can J Neurol Sci; 2013 May; 40(3):384-8. PubMed ID: 23603176
[TBL] [Abstract][Full Text] [Related]
37. The use of IVIg in the treatment of inflammatory polyneuropathies and myasthenia gravis at The Walton Centre.
Kimyongur S; Hywel B; Holt J
J R Coll Physicians Edinb; 2019 Mar; 49(1):5-11. PubMed ID: 30838984
[TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes of intravenous immunoglobulin therapy in refractory uveitis.
Garcia-Geremias M; Carreño E; Epps SJ; Lee RW; Dick AD
Int Ophthalmol; 2015 Apr; 35(2):281-5. PubMed ID: 25708281
[TBL] [Abstract][Full Text] [Related]
40. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]